2023 Pharmaceutical Manufacturing Trends

If we could predict the future of the pharma manufacturing industry, we wouldn’t have been rattled by supply disruptions throughout the pandemic. And we would’ve been able to anticipate which products would unexpectedly experience weak demand. At the very least, we could’ve predicted which winning therapies to invest in! So why do we waste time trying to predict future conditions when we could be preparing for them? Wishing for a crystal ball is a distraction when you have real opportunities today to start building for tomorrow. It’s time to control the things that are within your power to control and take advantage of technologies that will help you tackle the challenges of today while forging — not trying to predict — the industry’s future.

Although the future will always be unpredictable, the latest biotech and pharma manufacturing trends all share an underlying theme: adaptability. It’s the key to persevering in uncertain, ultra-competitive times. To develop adaptability at the individual company level, pharma manufacturers find themselves needing to be “more focused on operational resilience and accelerating initiatives that enable more agility — including workforce agility as workforces become more remote and distributed — and transparency through greater deployment of digital and analytics tools and automation,” according to McKinsey’s latest industry findings.¹

If adaptability, versatility, and agility are the keys to survival in a competitive and evolving industry, advanced technologies are the definitive means by which pharma manufacturers can make it a reality. Explore trends that reveal opportunities for pharma manufacturers to become more adaptable and highlight various ways that modern digital tools can help them realize that adaptability.